AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

D-FW biotech firm completes “first ever” AI clinical trial

AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Post page · Page 149 of 1608 · TechNode

Insilico Medicine achieves AI drug discovery breakthrough

A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs

TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

TIM-3 antibody (LY3321367)_Solid tumor_Phase1｜Clinical Cancer Trial Reports

How AI and Automation Transforming Clinical Trials

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Insilico Medicine achieves AI drug discovery breakthrough

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

TechNode